
Secarna Pharmaceuticals has appointed Jens Holstein and Richard Mark Engelhard to its new Advisory Board. As part of the board, …

Secarna Pharmaceuticals has announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio. The collaboration, first announced …

Secarna Pharmaceuticals and Vect-Horus have announced that the companies will collaborate to develop RNA-targeted therapeutics capable of crossing the blood-brain …

Global biopharma company, Secarna Pharmaceuticals, and biotech investor, Cure.Bio, have announced signing a research and option agreement, intending to accelerate …

Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches ยฃ20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

